TIETOJA TÄSTÄ JAKSOSTA
After bitter arguments, threatened walkouts and heated all-night negotiations, delegates eventually reached a deal this weekend at the Cop30 climate summit in Brazil. To unpick what was achieved and what was left out, Madeleine Finlay hears from the Guardian’s environment editor, Fiona Harvey, who has been following every twist and turn. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>
Englanti
Yhdistynyt kuningaskunta
TÄSSÄ EPISODISSA
TRANSKRIPTIO 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
HAE EDELLISIÄ EPISODEJA
Hae kanavan Science Weekly vanhoja jaksoja.
MUITA jaksoja TÄSSÄ PODCASTISSA
Madeleine Finlay hears from Steve Ramirez, an associate professor of psychological and brain sciences at Boston University, whose book How to Change a Memory was shortlisted for this year’s Royal Society Trivedi science book prize. He explains how scientists have been able to locate memories in the…
Madeleine Finlay sits down with her co-host and Guardian science editor, Ian Sample, to discuss three science stories from the week, including a study that offers a clue in the age-old debate about whether sex differences are present from birth or a product of socialisation. Also on the agenda is t…
Our use of cleaning products has increased since the pandemic, but do we understand what they could be doing to our health? The journalist Rebecca Seal recently wrote for the Guardian about the potential impacts of the many chemicals we now use in our homes. She tells Madeleine Finlay how social me…
As diet trends proliferate on social media, it can be hard to work out which are backed by science and which should be ignored. From paleo to keto, raw food to intermittent fasting, each attracts a tribe of ardent followers. Now Daniel Lieberman, professor of biological sciences at Harvard Universi…
The sleep disorder has been the butt of jokes and a comedic plot point, but the reality of living with narcolepsy is anything but funny. Things could be about to change for people with the condition though, after the US Food and Drug Administration (FDA) approved the first ever drug to treat narcol…
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin The Guardian:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.
MUOKKAA
Kiitos, kun autoit pitämään podcast-tietokantaa ajan tasalla.
